IP Library › Granted Patent US 12,279,951
Granted Patent B2
US 12,279,951 · App. 18/201,900 · Granted Apr 22, 2025

Transcatheter heart valve prosthesis assembled inside heart chambers or blood vessels

Inventors: Ramji Iyer (Plymouth, MN); Stephen Anderson (Minneapolis, MN); Samuel Thomas Johnson (Maple Grove, MN)
Assignee: Laplace Interventional Inc.
A61F2/2418A61F2/2436
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,279,951
App. No.
18/201,900
Granted
Apr 22, 2025
Kind
B2
Abstract

Some embodiments described herein include a heart valve replacement system that may be delivered to the targeted heart valve site via a delivery catheter. In some embodiments, the heart valve replacement system can assemble a valve device after the valve device is delivered to the heart. In some embodiments, heart valve replacement system includes two anterior flaps that are separate but overlap each other.

Claims (34)

1. A method of implanting a prosthetic tricuspid valve in a patient, the method comprising:

advancing a delivery sheath containing the prosthetic tricuspid valve in a collapsed delivery configuration through a superior vena cava of the patient and toward a native tricuspid valve of the patient, wherein the prosthetic tricuspid valve comprises:

a main body comprising an occluder having valve leaflets arranged to allow flow through the main body from an inlet end to an outlet end; and

an anterior flap extending laterally from the outlet end of the main body;

expressing the prosthetic tricuspid valve from the delivery sheath, wherein the outlet end is expressed from the delivery sheath prior to the inlet end; and

implanting the prosthetic tricuspid valve in the native tricuspid valve such that the anterior flap extends into a right ventricular outflow tract of the patient.

2. The method of claim 1 , wherein the prosthetic tricuspid valve further comprises a second anterior flap extending laterally from the outlet end of the main body in a same direction as the first anterior flap, and wherein second anterior flap extends into the right ventricular outflow tract of the patient.

3. The method of claim 2 , wherein portions of the anterior flap and the second anterior flap overlap each other in the right ventricular outflow tract of the patient.

4. The method of claim 3 , wherein the portions of the first and second anterior flaps that overlap each other increase a bending resistance of the first and second anterior flaps.

5. The method of claim 1 , wherein the anterior flap and the posterior flap are each expressed from a delivery sheath prior to the main body.

6. The method of claim 1 , wherein a distal tip portion of the posterior flap extends along an axis that is at a non-zero angle relative to a portion of the posterior flap that extends directly from the main body, and wherein the distal tip portion conforms with a wall of the right ventricle adjacent a posterior leaflet of the native tricuspid valve.

7. The method of claim 1 , wherein, during the advancing, the prosthetic tricuspid valve is disposed within a first lumen of a sheath catheter in a low profile delivery configuration and is releasably attached to both an outer proximal catheter and an inner distal catheter, wherein the outer proximal catheter is slidably disposed within the first lumen and defines a second lumen, and wherein the inner distal catheter is slidably disposed within the second lumen.

8. The method of claim 7 , wherein the main body is releasably attached to the outer proximal catheter, and wherein the anterior flap is releasably attached to the inner distal catheter.

9. A method of treating tricuspid valve regurgitation of a native tricuspid valve that has a pre-existing pacemaker lead extending therethrough, the method comprising:

advancing a prosthetic tricuspid valve through a superior vena cava of the patient and toward the native tricuspid valve, wherein the prosthetic tricuspid valve comprises:

a main body comprising an occluder having valve leaflets arranged to allow flow through the main body from an inlet end to an outlet end; and

an anterior flap extending laterally from the outlet end of the main body; and

implanting the prosthetic tricuspid valve in the native tricuspid valve such that the pacemaker lead passes through the prosthetic tricuspid valve.

10. The method of claim 9 , wherein the anterior flap extends into a right ventricular outflow tract of the patient.

11. The method of claim 9 , wherein the prosthetic tricuspid valve further comprises a second anterior flap, and wherein portions of the anterior flap and the second anterior flap overlap each other when the prosthetic tricuspid valve is implanted in the native tricuspid valve.

12. The method of claim 1 , wherein the first and second anterior flaps wrap around the pacemaker lead.

13. The method of claim 9 , wherein the prosthetic tricuspid valve further comprises a posterior flap, wherein a distal tip portion of the posterior flap extends along an axis that is at a non-zero angle relative to a portion of the posterior flap that extends directly from the main body, and wherein the distal tip portion conforms with a posterior section of a right ventrical wall behind a posterior leaflet of the native tricuspid valve.

14. A method of implanting a prosthetic tricuspid valve in a patient, the method comprising:

advancing the prosthetic tricuspid valve through a superior vena cava of the patient and toward a native tricuspid valve of the patient, wherein the prosthetic tricuspid valve comprises:

a main body comprising an occluder having valve leaflets arranged to allow flow through the main body from an inlet end to an outlet end; and

an anterior flap extending laterally from the outlet end of the main body;

a posterior flap, wherein a distal tip portion of the posterior flap extends along an axis that is at a non-zero angle relative to a portion of the posterior flap that extends directly from the main body; and

implanting the prosthetic tricuspid valve in an opening defined by an annulus of the native tricuspid valve,

wherein a first portion of the opening defined by the annulus of the native tricuspid valve is filled by the main body and a second portion of the opening defined by the annulus of the native tricuspid valve is covered by the anterior flap, and

wherein the distal tip portion conforms with a posterior section of a right ventricle wall behind a posterior leaflet of the native tricuspid valve.

15. The method of claim 14 , wherein the prosthetic tricuspid valve further comprises a second anterior flap, wherein a third portion of the opening defined by the native tricuspid valve is covered by the second anterior flap.

16. The method of claim 15 , wherein the anterior flap and second anterior flap each extend into a right ventricular outflow tract of the patient.

17. The method of claim 15 , wherein portions of the anterior flap and the second anterior flap overlap each other when the prosthetic tricuspid valve is implanted in the native tricuspid valve.

18. The method of claim 14 , wherein a third portion of the opening defined by the annulus of the native tricuspid valve is covered by the posterior flap.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2023
From: IYER, RAMJI
To: LAPLACE INTERVENTIONAL INC.
Reel/Frame 064040/0802 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2023
From: JOHNSON, SAMUEL THOMAS
To: NPX MEDICAL, LLC
Reel/Frame 064040/0828 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2023
From: ANDERSON, STEPHEN
To: HAARSTAD ENGINEERING SERVICE
Reel/Frame 064040/0855 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2023
From: NPX MEDICAL, LLC
To: LAPLACE INTERVENTIONAL INC.
Reel/Frame 064040/0891 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2023
From: HAARSTAD ENGINEERING SERVICE
To: LAPLACE INTERVENTIONAL INC.
Reel/Frame 064040/0932 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2023
From: IYER, RAMJI
To: LAPLACE INTERVENTIONAL LLC
Reel/Frame 064041/0091 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2023
From: LAPLACE INTERVENTIONAL LLC
To: LAPLACE INTERVENTIONAL INC.
Reel/Frame 064041/0128 →
Continuity (6)
Continuation 17747523 · May 18, 2022
Continuation 17465172 · Sep 2, 2021
Continuation 17165244 · Feb 2, 2021
Provisional Application 63130201 · Dec 23, 2020
Provisional Application 62970967 · Feb 6, 2020
Related Publication 20230320846A1 · Oct 12, 2023
References Cited (87)
US 5824069A · Lemole · 1998 [cited by applicant]
US 6312464B1 · Navia · 2001 [cited by applicant]
US 6458153B1 · Bailey et al. · 2002 [cited by applicant]
US 8728155B2 · Montorfano et al. · 2014 [cited by applicant]
US 9393110B2 · Levi et al. · 2016 [cited by applicant]
US 9579196B2 · Morriss · 2017 [cited by applicant]
US 9681951B2 · Ratz et al. · 2017 [cited by applicant]
US 10213307B2 · Dwork · 2019 [cited by applicant]
US 10321995B1 · Christianson · 2019 [cited by examiner]
US 10583000B2 · Ratz · 2020 [cited by applicant]
US 10595994B1 · Christianson · 2020 [cited by examiner]
US 10653522B1 · Vidlund · 2020 [cited by examiner]
US 10779936B2 · Pollak · 2020 [cited by applicant]
US 10813779B2 · Fleming, III et al. · 2020 [cited by applicant]
US 11234813B2 · Perrin · 2022 [cited by examiner]
US 11253359B2 · Vidlund · 2022 [cited by examiner]
US 11510777B1 · Iyer et al. · 2022 [cited by applicant]
US 20050149181A1 · Eberhardt · 2005 [cited by applicant]
US 20070055356A1 · Eidenschink · 2007 [cited by applicant]
US 20080065204A1 · Macoviak et al. · 2008 [cited by applicant]
US 20090281618A1 · Hill · 2009 [cited by examiner]
US 20100023046A1 · Heidner et al. · 2010 [cited by applicant]
US 20100036479A1 · Hill · 2010 [cited by examiner]
US 20100161045A1 · Righini · 2010 [cited by applicant]
US 20100217382A1 · Chau et al. · 2010 [cited by applicant]
US 20100316830A1 · Hartley et al. · 2010 [cited by applicant]
US 20110137397A1 · Chau et al. · 2011 [cited by applicant]
US 20110319989A1 · Lane et al. · 2011 [cited by applicant]
US 20120083832A1 · Delaloye et al. · 2012 [cited by applicant]
US 20130190861A1 · Chau et al. · 2013 [cited by applicant]
US 20130211508A1 · Lane et al. · 2013 [cited by applicant]
US 20130325110A1 · Khalil et al. · 2013 [cited by applicant]
US 20140135910A1 · Hauser · 2014 [cited by examiner]
US 20140207231A1 · Hacohen et al. · 2014 [cited by applicant]
US 20140222142A1 · Kovalsky et al. · 2014 [cited by applicant]
US 20140257467A1 · Lane et al. · 2014 [cited by applicant]
US 20140277390A1 · Ratz · 2014 [cited by applicant]
US 20140296969A1 · Tegels et al. · 2014 [cited by applicant]
US 20140296975A1 · Tegels et al. · 2014 [cited by applicant]
US 20140350669A1 · Gillespie et al. · 2014 [cited by applicant]
US 20150073544A1 · Gorman, III · 2015 [cited by examiner]
US 20150119981A1 · Khairkhahan et al. · 2015 [cited by applicant]
US 20150196390A1 · Ma et al. · 2015 [cited by applicant]
US 20150216653A1 · Freudenthal · 2015 [cited by applicant]
US 20150327994A1 · Morriss et al. · 2015 [cited by applicant]
US 20160158003A1 · Wallace et al. · 2016 [cited by applicant]
US 20160262887A1 · Chang et al. · 2016 [cited by applicant]
US 20160278922A1 · Braido et al. · 2016 [cited by applicant]
US 20170056166A1 · Ratz et al. · 2017 [cited by applicant]
US 20170071733A1 · Ghione et al. · 2017 [cited by applicant]
US 20170128199A1 · Gurovich et al. · 2017 [cited by applicant]
US 20170128208A1 · Christianson et al. · 2017 [cited by applicant]
US 20170128209A1 · Morriss et al. · 2017 [cited by applicant]
US 20170216023A1 · Lane et al. · 2017 [cited by applicant]
US 20170216026A1 · Quill et al. · 2017 [cited by applicant]
US 20170325945A1 · Dale et al. · 2017 [cited by applicant]
US 20180000586A1 · Ganesan · 2018 [cited by applicant]
US 20180318071A1 · Lozonschi · 2018 [cited by examiner]
US 20180368977A1 · Gorman et al. · 2018 [cited by applicant]
US 20190008635A1 · Francis et al. · 2019 [cited by applicant]
US 20190008636A1 · Francis et al. · 2019 [cited by applicant]
US 20190029811A1 · Bishop et al. · 2019 [cited by applicant]
US 20200121452A1 · Saikrishnan · 2020 [cited by examiner]
US 20200179109A1 · Reimer · 2020 [cited by applicant]
US 20200188097A1 · Perrin · 2020 [cited by examiner]
US 20200237506A1 · Christianson · 2020 [cited by examiner]
US 20200268512A1 · Mohl · 2020 [cited by applicant]
US 20210154011A1 · Christianson et al. · 2021 [cited by applicant]
US 20210186693A1 · Vidlund, I · 2021 [cited by examiner]
US 20210220126A1 · Perrin · 2021 [cited by examiner]
US 20210220127A1 · Vidlund · 2021 [cited by examiner]
US 20210236280A1 · Christianson · 2021 [cited by examiner]
US 20210244535A1 · Iyer · 2021 [cited by examiner]
US 20210259830A1 · Enriquez-Sarano · 2021 [cited by applicant]
US 20210346153A1 · Vietmeier et al. · 2021 [cited by applicant]
US 20210315694A1 · Vidlund · 2021 [cited by examiner]
US 20210330459A1 · Christianson · 2021 [cited by examiner]
US 20210369454A1 · Stack et al. · 2021 [cited by applicant]
US 20210401572A1 · Nasr · 2021 [cited by examiner]
US 20220160499A1 · Miyashiro et al. · 2022 [cited by applicant]
US 20220409369A1 · Christianson et al. · 2022 [cited by applicant]
EP 3520736A1 · 2019 [cited by applicant]
WO WO2009094500 · 2009 [cited by applicant]
WO WO2015052570 · 2015 [cited by applicant]
Extended European Search Report in European Appln No. 21750572.6, dated May 23, 2023, 10 pages. [cited by applicant]
Invitation to Pay Additional Fees in International Application No. PCT/US2021/016150, dated Apr. 6, 2021, 2 pages. [cited by applicant]
PCT International Search Report and Written Opinion in International Appln. No. PCT/US2021/016150, dated Jun. 29, 2021, 17 pages. [cited by applicant]